1. Home
  2. MESO vs ARCO Comparison

MESO vs ARCO Comparison

Compare MESO & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MESO
  • ARCO
  • Stock Information
  • Founded
  • MESO 2004
  • ARCO 2007
  • Country
  • MESO Australia
  • ARCO Uruguay
  • Employees
  • MESO N/A
  • ARCO N/A
  • Industry
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • ARCO Restaurants
  • Sector
  • MESO Health Care
  • ARCO Consumer Discretionary
  • Exchange
  • MESO Nasdaq
  • ARCO Nasdaq
  • Market Cap
  • MESO 1.3B
  • ARCO 1.4B
  • IPO Year
  • MESO N/A
  • ARCO 2011
  • Fundamental
  • Price
  • MESO $14.82
  • ARCO $6.79
  • Analyst Decision
  • MESO Buy
  • ARCO Buy
  • Analyst Count
  • MESO 3
  • ARCO 2
  • Target Price
  • MESO $18.00
  • ARCO $10.40
  • AVG Volume (30 Days)
  • MESO 230.7K
  • ARCO 1.3M
  • Earning Date
  • MESO 08-28-2025
  • ARCO 11-12-2025
  • Dividend Yield
  • MESO N/A
  • ARCO 3.53%
  • EPS Growth
  • MESO N/A
  • ARCO N/A
  • EPS
  • MESO N/A
  • ARCO 0.62
  • Revenue
  • MESO $17,198,000.00
  • ARCO $4,496,793,000.00
  • Revenue This Year
  • MESO $293.59
  • ARCO $6.86
  • Revenue Next Year
  • MESO $218.64
  • ARCO $8.06
  • P/E Ratio
  • MESO N/A
  • ARCO $10.99
  • Revenue Growth
  • MESO 191.39
  • ARCO 0.09
  • 52 Week Low
  • MESO $6.00
  • ARCO $6.51
  • 52 Week High
  • MESO $22.00
  • ARCO $10.27
  • Technical
  • Relative Strength Index (RSI)
  • MESO 50.33
  • ARCO 43.04
  • Support Level
  • MESO $12.66
  • ARCO $6.68
  • Resistance Level
  • MESO $15.67
  • ARCO $7.12
  • Average True Range (ATR)
  • MESO 0.45
  • ARCO 0.19
  • MACD
  • MESO -0.00
  • ARCO -0.00
  • Stochastic Oscillator
  • MESO 59.83
  • ARCO 21.15

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

About ARCO Arcos Dorados Holdings Inc. Shares

Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.

Share on Social Networks: